Table 1 Baseline characteristics
Variables | No AKI (N = 88) | AKI (N = 117) | p-value* |
|---|---|---|---|
Age (years) | 57 [48–64] | 57 [51–62] | 0.85 |
Male (%) | 61 (69) | 83 (71) | 0.76 |
Weight (kg) | 75 [61–83] | 83 [70–94] | 0.019 |
ASA score (II/III/IV/V) | 4/55/28/1 | 1/56/57/3 | 0.99 |
Comorbid conditions | |||
➢ Myocardial injury (%) | 5 (6) | 5 (4) | 0.61 |
➢ Arterial hypertension (%) | 52 (59) | 73 (62) | 0.88 |
➢ Heart failure (%) | 1 (1) | 1 (1) | 0.71 |
➢ Hyperlipidaemia (%) | 8 (9) | 28 (24) | 0.055 |
➢ Diabetes mellitus (%) | 26 (30) | 32 (27) | 0.16 |
➢ Atrial fibrillation (%) | 8 (9) | 11 (9) | 0.75 |
➢ COPD (%) | 5 (6) | 4 (3) | 0.61 |
➢ Peripheral arteritis (% | 4 (5) | 5 (4) | 0.76 |
Medication | |||
➢ β blocker (%) | 42 (47) | 50 (43) | 0.77 |
➢ ACEI (%) | 6 (7) | 8 (7) | 0.87 |
➢ ARB (%) | 2 (2) | 1 (1) | 0.99 |
➢ Diuretics (%) | 34 (39) | 64 (55) | 0.039 |
➢ Statin (%) | 9 (9) | 13 (11) | 0.75 |
Child-Pugh score | 7 [5-12] | 11 [7-13] | 0.022 |
MELD score | 12 [9-20] | 19 [14-29] | 0.014 |
Fulminant hepatitis (%) | 4 (5) | 8 (7) | 0.81 |
Haemoglobin (g/dL) | 12.1 [9.5–13.6] | 10.4 [8.9–12.7] | 0.014 |
Creatinine (mg/dL) | 0.90 [0.70–1.19] | 1.00 [0.70–1.32] | 0.061 |
HBV (%) | 14 (16) | 14 (12) | 0.86 |
HCV (%) | 17 (20) | 23 (20) | 0.23 |
Donor age (y) | 56 [46–66] | 57 [45–68] | 0.38 |
Donor BMI (kg/m2) | 25 [23-28] | 26 [24-28] | 0.14 |